section name header

Pronunciation

a-mee-TRIP-ti-leen

Classifications

Therapeutic Classification: antidepressants

Pharmacologic Classification: tricyclic antidepressants

Indications

BEERS REMS


Unlabeled Use:
  • Anxiety, insomnia, treatment-resistant depression.
  • Chronic pain syndromes (i.e., fibromyalgia, neuropathic pain/chronic pain, headache, low back pain).

Action

  • Potentiates the effect of serotonin and norepinephrine in the CNS.
  • Has significant anticholinergic properties.
Therapeutic effects:
  • Antidepressant action.

Pharmacokinetics

Absorption: Well absorbed from the GI tract.

Distribution: Widely distributed.

Protein Binding: 95% bound to plasma proteins.

Metabolism/Excretion: Extensively metabolized by the liver, primarily by the CYP2D6 isoenzyme; the CYP2D6 enzyme system exhibits genetic polymorphism (7% of population may be poor metabolizers and may have significantly amitriptyline concentrations and an risk of adverse effects). Some metabolites have antidepressant activity. Undergoes enterohepatic recirculation and secretion into gastric juices. Probably crosses the placenta and enters breast milk.

Half-Life: 10–50 hr.

Time/Action Profile

(antidepressant effect)

ROUTEONSETPEAKDURATION
PO2–3 wk (up to 30 days)2–6 wkdays–wk



Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypotension, ARRHYTHMIAS, QT interval prolongation, TORSADES DE POINTES

Derm: photosensitivity

EENT: blurred vision, dry eyes, dry mouth

Endo: changes in blood glucose, gynecomastia

GI: constipation, hepatitis, paralytic ileus

GU: libido, urinary retention

Hemat: blood dyscrasias

Metab: appetite, weight gain

Neuro: lethargy, sedation, SUICIDAL THOUGHTS

Interactions

Drug-drug:

Drug-Natural Products:

Route/Dosage

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

Canadian Brand Names

Elavil

Pill Image

amitriptylinehcl_195-1815.jpg

Code

NDC Code